Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Gastrointestinal Function Recovery After Lumbar Spine Surgery
NCT07307495Recruiting
- Sponsor
- Xijing Hospital
- Start
- Mar 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by Xijing Hospital. Primary endpoint: Proportion of patients reaching the GI-3 composite endpoint at 24 hours. Started Mar 2026; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07307495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07307495.